Back إليومينا Arabic ایلومینا AZB Illumina (empresa) Catalan Illumina German Illumina (compañía) Spanish Illumina Estonian ایلومینا Persian Illumina French אילומינה HE Illumina (perusahaan) ID
 | |
| Company type | Public |
|---|---|
| |
| Industry | Biotechnology |
| Founded | 1998 |
| Founders |
|
| Headquarters | , U.S. |
Key people | |
| Products |
|
| Revenue |  US$4.50 billion (2023) |
 US$−1.1 billion (2023) | |
| US$−1.2 billion (2023) | |
| Total assets | US$10.1 billion (2023) |
| Total equity | US$5.75 billion (2023) |
Number of employees | approx. 9,250 (2023) |
| Website | illumina.com |
| Footnotes / references [1] | |
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.[2]
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.[1]
- ^ a b "US SEC:Form 10-K Illumina, Inc". U.S. Securities and Exchange Commission. 16 February 2024. Archived from the original on 17 February 2024. Retrieved 17 February 2024.
- ^ Morrison, Mary E. (May 31, 2023). "At Illumina, Breaking DownBarriers to Democratize Genomics". Wall Street Journal. Deloitte. Archived from the original on November 8, 2023. Retrieved November 8, 2023.